These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27196975)

  • 21. Dopamine D2 receptor signaling on iMSNs is required for initiation and vigor of learned actions.
    Augustin SM; Loewinger GC; O'Neal TJ; Kravitz AV; Lovinger DM
    Neuropsychopharmacology; 2020 Nov; 45(12):2087-2097. PubMed ID: 32811899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
    Marshall JF; Henry BL; Billings LM; Hoover BR
    Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission.
    Beggiato S; Tomasini MC; Borelli AC; Borroto-Escuela DO; Fuxe K; Antonelli T; Tanganelli S; Ferraro L
    J Neurochem; 2016 Jul; 138(2):254-64. PubMed ID: 27127992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatum.
    Navntoft CA; Dreyer JK
    Mov Disord; 2016 Mar; 31(3):280-9. PubMed ID: 26890687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
    Centonze D; Gubellini P; Usiello A; Rossi S; Tscherter A; Bracci E; Erbs E; Tognazzi N; Bernardi G; Pisani A; Calabresi P; Borrelli E
    Neuroscience; 2004; 129(1):157-66. PubMed ID: 15489038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
    J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation.
    Stefani A; Spadoni F; Martorana A; Lavaroni F; Martella G; Sancesario G; Bernardi G
    Eur J Neurosci; 2002 Mar; 15(5):815-25. PubMed ID: 11906523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is nicotine protective against Parkinson's disease? An experimental analysis.
    García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
    Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN;
    Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapallidal D2 dopamine receptors control globus pallidus neuron activity in the rat.
    Querejeta E; Delgado A; Valdiosera R; Erlij D; Aceves J
    Neurosci Lett; 2001 Mar; 300(2):79-82. PubMed ID: 11207379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Cdc42 signaling by the dopamine D2 receptor in a mouse model of Parkinson's disease.
    Ying L; Zhao J; Ye Y; Liu Y; Xiao B; Xue T; Zhu H; Wu Y; He J; Qin S; Jiang Y; Guo F; Zhang L; Liu N; Zhang L
    Aging Cell; 2022 May; 21(5):e13588. PubMed ID: 35415964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced striatopallidal gamma-aminobutyric acid (GABA)
    Perez-Rosello T; Gelman S; Tombaugh G; Cachope R; Beaumont V; Surmeier DJ
    Mov Disord; 2019 May; 34(5):684-696. PubMed ID: 30726572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum.
    Mallet N; Delgado L; Chazalon M; Miguelez C; Baufreton J
    Cells; 2019 Aug; 8(9):. PubMed ID: 31470672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.